
Pacific Biosciences of California, Inc.· PACB
- Price
- $1.38
- Day
- +2.99%
- Mkt Cap
- $428.63M
- 52W Range
- $1.07 – $2.73
- Volume
- 6.23M
- Beta
- 2.31

Find a company by name or ticker and open its page
Insider activity, institutional flows, and fund ownership.
Insider trading analysis comparing the latest quarter against the stock's own historical baseline.
Neutral
Routine insider selling in Q3 2026
1 sale totaling $30.4K (26.9K shares)
Share volume is well below the historical pace (0.1x average), insiders are holding more
Buying seen in 1 of 15 quarters
Selling pace
quarter in progress, filings still arriving
Stake sold
of active insiders' holdings
Seller breadth
vs 1.5 avg per quarter
Last insider purchase
buying in 1 of 16 quarters
Institutional ownership analysis with position momentum, 13F share flow, and ownership percentage trends.
Neutral
Mixed institutional activity in Q2 2026
62.4% institutional ownership
Balanced activity: 118 adding vs 111 reducing
13F shares increased by 2.9%, a notable change
Momentum weakening from prior quarter
Net breadth
118 adding vs 111 reducing
Balanced
Add / reduce ratio
in Q2 2026
New − closed
25 initiated, 33 exited
Top holders adding
largest holders with a known change
ETF and mutual fund activity breakdown showing buying vs selling funds, top fund holders, and detailed holdings.
Very Bullish
Funds accumulating in Q2 2026
231 ETFs and mutual funds reporting
39 funds buying vs 16 selling